It’s been more than 150 years since doctors first diagnosed blood cancers, and for most of that time, there was no effective treatment or cure. Chemotherapy led to advances and gave many patients longer life and improved health, but for many, leukemia and lymphoma remained among the hardest cancers to treat. Thanks to advances in immunology and an ever-improving understanding of genomics and proteomics – the role genes and proteins play in disease and its progression – scientists and clinicians are able to identify unique markers present on blood cancers and modify healthy cells from our own immune system to find and destroy them. Hear from Dr. Komanduri about where the science is headed, and the remarkable breakthroughs in cancer treatment that will shape the future of care.